Overview
Agnieszka Nikolajuk practices in Olsztyn, Poland. Ms. Nikolajuk is rated as an Advanced expert by MediFind in the treatment of Obesity. Her top areas of expertise are Ovarian Cysts, Polycystic Ovary Syndrome, Obesity, Type 2 Diabetes (T2D), and Tissue Biopsy.
Her clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 21 articles in the study of Obesity.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ovarian CystsMs. Nikolajuk isDistinguished. Learn about Ovarian Cysts.
- Advanced
- ObesityMs. Nikolajuk isAdvanced. Learn about Obesity.
- Polycystic Ovary SyndromeMs. Nikolajuk isAdvanced. Learn about Polycystic Ovary Syndrome.
- Type 2 Diabetes (T2D)Ms. Nikolajuk isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- AtherosclerosisMs. Nikolajuk isExperienced. Learn about Atherosclerosis.
- HyperthyroidismMs. Nikolajuk isExperienced. Learn about Hyperthyroidism.
- RUNX1 Familial Platelet DisorderMs. Nikolajuk isExperienced. Learn about RUNX1 Familial Platelet Disorder.
- Tissue BiopsyMs. Nikolajuk isExperienced. Learn about Tissue Biopsy.
- Type 1 Diabetes (T1D)Ms. Nikolajuk isExperienced. Learn about Type 1 Diabetes (T1D).
- Type B Insulin Resistance SyndromeMs. Nikolajuk isExperienced. Learn about Type B Insulin Resistance Syndrome.